149 related articles for article (PubMed ID: 32948135)
1. Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.
Linke C; Wösle M; Harder A
BMC Cancer; 2020 Sep; 20(1):896. PubMed ID: 32948135
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate.
Pereira da Silva AP; El-Bacha T; Kyaw N; dos Santos RS; da-Silva WS; Almeida FC; Da Poian AT; Galina A
Biochem J; 2009 Feb; 417(3):717-26. PubMed ID: 18945211
[TBL] [Abstract][Full Text] [Related]
3. 3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: In vitro and in vivo studies.
Chen F; Wang H; Lai J; Cai S; Yuan L
Int J Cardiol; 2018 Sep; 266():236-241. PubMed ID: 29735421
[TBL] [Abstract][Full Text] [Related]
4. MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro.
Fischer-Huchzermeyer S; Dombrowski A; Wilke G; Stahn V; Streubel A; Mautner VF; Harder A
PLoS One; 2017; 12(11):e0187700. PubMed ID: 29131833
[TBL] [Abstract][Full Text] [Related]
5. 3-Bromopyruvate Attenuates Experimental Pulmonary Hypertension via Inhibition of Glycolysis.
Zhang YL; Zhang R; Shen YF; Huang KY; He YY; Zhao JH; Jing ZC
Am J Hypertens; 2019 Mar; 32(4):426-432. PubMed ID: 30561502
[TBL] [Abstract][Full Text] [Related]
6. 3-Bromopyruvate decreased kidney fibrosis and fibroblast activation by suppressing aerobic glycolysis in unilateral ureteral obstruction mice model.
Yu H; Zhu J; Chang L; Liang C; Li X; Wang W
Life Sci; 2021 May; 272():119206. PubMed ID: 33577854
[TBL] [Abstract][Full Text] [Related]
7. Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In Vivo.
Schulte A; Ewald F; Spyra M; Smit DJ; Jiang W; Salamon J; Jücker M; Mautner VF
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102484
[TBL] [Abstract][Full Text] [Related]
8. 3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants.
Konstantakou EG; Voutsinas GE; Velentzas AD; Basogianni AS; Paronis E; Balafas E; Kostomitsopoulos N; Syrigos KN; Anastasiadou E; Stravopodis DJ
Mol Cancer; 2015 Jul; 14():135. PubMed ID: 26198749
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro.
Zhang Q; Pan J; Lubet RA; Komas SM; Kalyanaraman B; Wang Y; You M
Cancer Prev Res (Phila); 2015 Apr; 8(4):318-26. PubMed ID: 25644152
[TBL] [Abstract][Full Text] [Related]
10. 3-bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial-mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth.
Wang TA; Zhang XD; Guo XY; Xian SL; Lu YF
Oncol Rep; 2016 Mar; 35(3):1287-96. PubMed ID: 26708213
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of energy metabolism by 3-bromopyruvate in the hard tick Rhipicephalus microplus.
Braz V; Gomes H; Galina A; Saramago L; Braz G; da Silva Vaz I; Logullo C; da Fonseca RN; Campos E; Moraes J
Comp Biochem Physiol C Toxicol Pharmacol; 2019 Apr; 218():55-61. PubMed ID: 30580107
[TBL] [Abstract][Full Text] [Related]
12. 3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells.
Sun X; Sun G; Huang Y; Hao Y; Tang X; Zhang N; Zhao L; Zhong R; Peng Y
Biochem Pharmacol; 2020 Jul; 177():113988. PubMed ID: 32330495
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine.
Orue A; Chavez V; Strasberg-Rieber M; Rieber M
BMC Cancer; 2016 Nov; 16(1):902. PubMed ID: 27863474
[TBL] [Abstract][Full Text] [Related]
14. MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors.
Borcherding DC; Amin NV; He K; Zhang X; Lyu Y; Dehner C; Bhatia H; Gothra A; Daud L; Ruminski P; Pratilas CA; Pollard K; Sundby T; Widemann BC; Hirbe AC
Clin Cancer Res; 2023 Apr; 29(8):1592-1604. PubMed ID: 36799629
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells.
Zou X; Zhang M; Sun Y; Zhao S; Wei Y; Zhang X; Jiang C; Liu H
Oncol Rep; 2015 Oct; 34(4):1895-904. PubMed ID: 26239511
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
17. Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells.
Xiao H; Li S; Zhang D; Liu T; Yu M; Wang F
Oncol Rep; 2013 Jan; 29(1):329-34. PubMed ID: 23076497
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth.
Yang K; Guo W; Ren T; Huang Y; Han Y; Zhang H; Zhang J
J Exp Clin Cancer Res; 2019 May; 38(1):185. PubMed ID: 31053152
[TBL] [Abstract][Full Text] [Related]
19. 3-Bromopyruvate: A new strategy for inhibition of glycolytic enzymes in Leishmania amazonensis.
Gomes MT; Paes-Vieira L; Gomes-Vieira AL; Cosentino-Gomes D; da Silva APP; Giarola NLL; Da Silva D; Sola-Penna M; Galina A; Meyer-Fernandes JR
Exp Parasitol; 2021 Oct; 229():108154. PubMed ID: 34481863
[TBL] [Abstract][Full Text] [Related]
20. MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors.
Birsoy K; Wang T; Possemato R; Yilmaz OH; Koch CE; Chen WW; Hutchins AW; Gultekin Y; Peterson TR; Carette JE; Brummelkamp TR; Clish CB; Sabatini DM
Nat Genet; 2013 Jan; 45(1):104-8. PubMed ID: 23202129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
